DL PHARMA +

Zulte ·KBO/BCE: BE 0755.325.637

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-03-2025	31-10-2025	31-10-2025	on the day	2025-00560635
31-03-2024	31-10-2024	25-09-2024	36 d early	2024-00470921
31-03-2023	31-10-2023	27-10-2023	4 d early	2023-00493951
31-03-2022	31-10-2022	26-10-2022	5 d early	2022-20472677

Line item	Code	2022
Balance sheet, Assets
TOTAL ASSETS	20/58	€28k
Fixed assets	21/28	€194
Tangible fixed assets	22/27	€194
Current assets	29/58	€28k
Amounts receivable within one year	40/41	€6k
Cash & bank	54/58	€21k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€28k
Equity	10/15	€15k
Contributions / capital	10/11	€5k
Reserves	13	€10k
Amounts payable	17/49	€13k
Amounts payable within one year	42/48	€13k
Trade debts payable within one year	44	€2k
Income statement
Gross operating margin	9900	€13k
Operating result	9901	€12k
Financial charges	65	€146
Result before taxes	9903	€12k
Income taxes	67/77	€3k
Net result for the period	9904	€10k
Result to be appropriated	9905	€10k

Summary